日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted delivery of RNA using synthetic bacterial spores

利用合成细菌孢子进行RNA靶向递送

Johnston, Robert K; Harper, Jason C; Tartis, Michaelann S; Machinandiarena, Federico; D’Atri, Domenico; Jenkins, Lisa M; Tanner, Kandice; Fitzgerald, David J; Ramamurthi, Kumaran S

Targeted delivery of RNA using synthetic bacterial spores

利用合成细菌孢子进行RNA靶向递送

Machinandiarena, Federico; D'Atri, Domenico; Jenkins, Lisa M; Tanner, Kandice; Fitzgerald, David J; Ramamurthi, Kumaran S

Targeted delivery of RNA using synthetic bacterial spores

利用合成细菌孢子进行RNA靶向递送

Umar, Sheriff; Catazaro, Jonathan; Wachira, James; Samokhvalov, Alexander; Machinandiarena, Federico; D’Atri, Domenico; Jenkins, Lisa M; Tanner, Kandice; Fitzgerald, David J; Ramamurthi, Kumaran S

Immunization with peptide encapsulated within synthetic spores activates T cell responses and reduces tumor growth.

用包裹在合成孢子中的肽进行免疫接种可以激活 T 细胞反应并减少肿瘤生长

D'Atri Domenico, Tondini Elena, Machinandiarena Federico, Kong Minsuk, Mia Alilin, Gallardo Devorah, Tanner Kandice, Hewitt Stephen M, Fitzgerald David J, Ramamurthi Kumaran S

Managing the TME to improve the efficacy of cancer therapy

通过管理肿瘤微环境(TME)来提高癌症治疗的疗效

Bilotta, Maria Teresa; Antignani, Antonella; Fitzgerald, David J

Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1

间皮素靶向免疫毒素疗法的抗癌作用受酪氨酸激酶DDR1调控

Ali-Rahmani, Fatima; FitzGerald, David J; Martin, Scott; Patel, Paresma; Prunotto, Marco; Ormanoglu, Pinar; Thomas, Craig; Pastan, Ira

Immunotoxins for leukemia

白血病的免疫毒素

Wayne, Alan S; Fitzgerald, David J; Kreitman, Robert J; Pastan, Ira

Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitors

降低HCK水平或使用SRC激酶抑制剂治疗可增强免疫毒素的抗肿瘤作用。

Liu, Xiu-Fen; Xiang, Laiman; FitzGerald, David J; Pastan, Ira

Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts

托法替尼可抑制小鼠宿主对蛋白质疗法的抗体反应

Onda, Masanori; Ghoreschi, Kamran; Steward-Tharp, Scott; Thomas, Craig; O'Shea, John J; Pastan, Ira H; FitzGerald, David J

Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia

抗CD22重组免疫毒素moxetumomab pasudotox(CAT-8015或HA22)治疗毛细胞白血病患者的I期临床试验

Kreitman, Robert J; Tallman, Martin S; Robak, Tadeusz; Coutre, Steven; Wilson, Wyndham H; Stetler-Stevenson, Maryalice; Fitzgerald, David J; Lechleider, Robert; Pastan, Ira